GlobeImmune hits IPO target by dropping price, bumping shares

GlobeImmune Inc. (NASDAQ:GBIM) was up $1.05 (11%) to $11.05 on its first day of trading Wednesday after raising $15 million through the sale of 1.5 million shares at $10 in an IPO. The price values GlobeImmune at $51.3 million. Aegis Capital is the underwriter.

On Monday, the company amended the offering to raise $15 million but through the sale of 1 million shares at $15. At that price, the company would have been valued at $69.4 million (see BioCentury Extra, June 30). ...